- Home
- IOBT vs ESLA Comparison
IOBT vs ESLA Comparison
Compare IOBT & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- ESLA
- Stock Information
- Founded
- IOBT 2014
- ESLA 2021
- Country
- IOBT Denmark
- ESLA United States
- Employees
- IOBT N/A
- ESLA N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IOBT Health Care
- ESLA Health Care
- Exchange
- IOBT Nasdaq
- ESLA Nasdaq
- Market Cap
- IOBT 56.7M
- ESLA 41.6M
- IPO Year
- IOBT 2021
- ESLA N/A
- Fundamental
- Price
- IOBT $0.83
- ESLA $1.07
- Analyst Decision
- IOBT Strong Buy
- ESLA
- Analyst Count
- IOBT 3
- ESLA 0
- Target Price
- IOBT $9.33
- ESLA N/A
- AVG Volume (30 Days)
- IOBT 218.7K
- ESLA 23.1K
- Earning Date
- IOBT 03-04-2025
- ESLA 02-12-2025
- Dividend Yield
- IOBT N/A
- ESLA N/A
- EPS Growth
- IOBT N/A
- ESLA N/A
- EPS
- IOBT N/A
- ESLA N/A
- Revenue
- IOBT N/A
- ESLA N/A
- Revenue This Year
- IOBT N/A
- ESLA N/A
- Revenue Next Year
- IOBT N/A
- ESLA N/A
- P/E Ratio
- IOBT N/A
- ESLA N/A
- Revenue Growth
- IOBT N/A
- ESLA N/A
- 52 Week Low
- IOBT $0.66
- ESLA $0.63
- 52 Week High
- IOBT $1.95
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- IOBT 42.77
- ESLA 44.96
- Support Level
- IOBT $0.87
- ESLA $1.02
- Resistance Level
- IOBT $0.95
- ESLA $1.22
- Average True Range (ATR)
- IOBT 0.09
- ESLA 0.17
- MACD
- IOBT -0.00
- ESLA -0.02
- Stochastic Oscillator
- IOBT 17.50
- ESLA 16.67
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.